Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1436]

Advances in metastatic non small cell lung cancer

Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany

Advances in metastatic non small cell lung cancer ( Dr Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )

PEACE: Collecting cancer tissue to solve the riddle of metastasis

Dr Mariam Jamal-Hanjani - UCL Cancer Institute and UCL Hospital, London, UK

PEACE: Collecting cancer tissue to solve the riddle of metastasis ( Dr Mariam Jamal-Hanjani - UCL Cancer Institute and UCL Hospital, London, UK )

Editor’s Choice for September 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor’s Choice for September 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

Editor's Choice for August 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor's Choice for August 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

Updates from a range of lung cancer studies

Prof Edgardo S. Santos - Lynn Cancer Institute, Boca Raton, USA

Updates from a range of lung cancer studies ( Prof Edgardo S. Santos - Lynn Cancer Institute, Boca Raton, USA )

Large B-cell lymphoma: ZUMA-1 trial

Dr Frederick Locke - Moffitt Cancer Center, Tampa, USA

Large B-cell lymphoma: ZUMA-1 trial ( Dr Frederick Locke - Moffitt Cancer Center, Tampa, USA )

Five practice changing shifts in oncology

Dr Jack West - Swedish Cancer Institute, Seattle, USA

Five practice changing shifts in oncology ( Dr Jack West - Swedish Cancer Institute, Seattle, USA )

Updates on data and results from PROPHECY, PALOMA-3 and CHECKMATE-227

Ignacio Gil-Bazo - Clínica Universidad de Navarra, Pamplona, Spain

Updates on data and results from PROPHECY, PALOMA-3 and CHECKMATE-227 ( Ignacio Gil-Bazo - Clínica Universidad de Navarra, Pamplona, Spain )

Two important pancreatic studies: PRODIGE 24 and PREOPANC

Dr Kenneth Yu - Memorial Sloan Kettering Cancer Center, New York, USA

Two important pancreatic studies: PRODIGE 24 and PREOPANC ( Dr Kenneth Yu - Memorial Sloan Kettering Cancer Center, New York, USA )

The PERSEPHONE trial: 6 months and 12 months of trastuzumab in breast cancer

Prof Mariana Chavez-McGregor - University of Texas MD Anderson Cancer Center...

The PERSEPHONE trial: 6 months and 12 months of trastuzumab in breast cancer ( Prof Mariana Chavez-McGregor - University of Texas MD Anderson Cancer Center, Houston, USA )

Key advances in ALL and AML

Dr Martin S. Tallman - Moffitt Cancer Center, Tampa, USA

Key advances in ALL and AML ( Dr Martin S. Tallman - Moffitt Cancer Center, Tampa, USA )

Four studies about relapsed myeloma and advanced disease

Prof Melissa Alsina -Moffitt Cancer Center, Tampa, USA

Four studies about relapsed myeloma and advanced disease ( Prof Melissa Alsina -Moffitt Cancer Center, Tampa, USA )

More from ecancer